Abstract:Among the nine subtypes of human voltage-gated sodium (Na-v) channels, the brain and cardiac isoforms, Na(v)1.1 and Na(v)1.5, each carry more than 400 missense mutations respectively associated with epilepsy and cardiac disorders. High-resolution structures are required for structure-function relationship dissection of the disease variants. We report the cryo-EM structures of the full-length human Na(v)1.1-beta 4 complex at 3.3 A resolution here and the Na(v)1.5-E1784K variant in the accompanying paper. Up to 341 and 261 disease-related missense mutations in Na(v)1.1 and Na(v)1.5, respectively, are resolved. Comparative structural analysis reveals several clusters of disease mutations that are common to both Na(v)1.1 and Na(v)1.5. Among these, the majority of mutations on the extracellular loops above the pore domain and the supporting segments for the selectivity filter may impair structural integrity, while those on the pore domain and the voltage-sensing domains mostly interfere with electromechanical coupling and fast inactivation. Our systematic structural delineation of these mutations provides important insight into their pathogenic mechanism, which will facilitate the development of precise therapeutic interventions against various sodium channelopathies.

Structure of human NaV1.6 channel reveals Na+ selectivity and pore blockade by 4,9-anhydro-tetrodotoxin

Structure of human NaV1.6 channel reveals Na<sup>+</sup>selectivity and pore blockade by 4,9-anhydro-tetrodotoxin

Structural basis for pore blockade of the human cardiac sodium channel Nav1.5 by tetrodotoxin and quinidine

High-resolution Structures of Human Nav1.7 Reveal Gating Modulation Through Α-Π Helical Transition of S6IV.

Structure of the Human Sodium Leak Channel NALCN in Complex with FAM155A

Structural mechanism of voltage-gated sodium channel slow inactivation.

Structures of Human Nav1.7 Channel in Complex with Auxiliary Subunits and Animal Toxins.

Cryo-EM structure of human voltage-gated sodium channel Nav1.6

Structural basis for modulation of human Na V 1.3 by clinical drug and selective antagonist

Structure of the Human Voltage-Gated Sodium Channel Nav1.4 in Complex with Β1.

Cryo-EM structure of human voltage-gated sodium channel Na <sub>v</sub> 1.6

Structural Basis Of Nav1.7 Inhibition By The Tarantula Toxin Protoxin-Ii

Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8.

Structural basis for the modulation of voltage-gated sodium channels by animal toxins

Structural basis for high-voltage activation and subtype-specific inhibition of human Na<sub>v</sub>1.8

Structural basis of inhibition of human NaV1.8 by the tarantula venom peptide Protoxin-I

Molecular Basis for Pore Blockade of Human Na+ Channel Nav1.2 by the Μ-Conotoxin KIIIA.

Structural basis for Na V 1.7 inhibition by pore blockers

Structural Mapping of Na V 1.7 Antagonists

Functional effects of drugs and toxins interacting with NaV1.4

Comparative structural analysis of human Na<sub>v</sub>1.1 and Na<sub>v</sub>1.5 reveals mutational hotspots for sodium channelopathies